Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear distribution protein nudE homolog 1 (NDE1) is a centrosomal scaffold/adaptor protein vital for neurodevelopment, especially cortical brain formation. It governs centrosome duplication, mitotic spindle formation, and the organization and orientation of microtubules during cell division, particularly in neural progenitors[1][3][5]. By controlling the axis of cell division, it influences the balance between neural progenitor expansion and differentiation, affecting total neuron numbers and cortical layering[1][3][5]. NDE1 interacts with LIS1 and dynein to regulate nuclear migration and mitotic spindle formation, and with chromatin modifiers to safeguard genome integrity during S phase, preventing DNA damage in developing neurons[2][4][5]. Loss-of-function mutations in both alleles cause severe developmental brain disorders such as lissencephaly with microcephaly, while heterozygous loss may raise cancer risk[2][3]. NDE1 is not currently considered a classical drug target (receptor, enzyme, transporter), but is instead a key player in cell architecture and genome safeguarding during neurodevelopment[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear distribution protein nudE homolog 1 (NDE1).